Related Experiment Video

Updated: Jun 10, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Design of virotherapy for effective tumor treatment

Eva Garcia-Aragoncillo1, Ruben Hernandez-Alcoceba

  • 1University of Navarra, Center for Applied Medical Research, Gene Therapy Unit, Avenue Pio XII 55, 31008 Pamplona, Spain. rubenh@unav.es

Current Opinion in Molecular Therapeutics
|August 3, 2010
PubMed

Insights

Virotherapy uses genetically modified viruses to treat cancer. Recent advances focus on improving oncolytic virus efficacy and understanding immune system interactions for better tumor treatment outcomes.

Area of Science:

  • Oncology
  • Virology
  • Immunotherapy

Background:

  • Virotherapy, using viruses to treat cancer, has seen a resurgence due to genetic engineering advancements.
  • Early clinical trials demonstrated safety but highlighted the need for improved therapeutic efficacy.

Purpose of the Study:

  • To review recent significant advances in designing virotherapy for effective cancer treatment.
  • To explore strategies for enhancing oncolytic virus efficacy and overcoming clinical limitations.

Main Methods:

  • Genetic modification of viral genomes to enhance oncolytic potential.
  • Incorporation of therapeutic genes into viral vectors.
  • Evaluation of alternative viruses and improved biodistribution methods.
  • Investigating the role of the immune system in virotherapy outcomes.

Main Results:

  • Demonstrated safety profiles of oncolytic viruses in human clinical settings.
  • Identified key strategies for improving virotherapy efficacy, including gene delivery and immune modulation.
  • Highlighted the complex interplay between the immune system and oncolytic viruses.

Conclusions:

  • Virotherapy holds significant promise for cancer treatment, with ongoing research focused on maximizing its effectiveness.
  • Future directions involve refining viral designs, optimizing delivery, and leveraging immunological insights for superior tumor targeting and eradication.

More Related Videos

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.